Healthcare - Biotechnology - NASDAQ - US
$ 0.17
-5.56 %
$ 11.1 M
Market Cap
-0.11
P/E
INCOME STATEMENT
1.56 M
REVENUE
-67.1 M
OPERATING INCOME
-62.7 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Lyra Therapeutics, Inc.
| Revenue | 1.56 M |
| Cost Of Revenue | 48 M |
| Gross Profit | -46.5 M |
| Operating Expenses | 20.6 M |
| Operating Income | -67.1 M |
| Other Expenses | -4.44 M |
| Net Income | -62.7 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 1.6 | 1.4 | 0.3 | 0 | 0 | 1.2 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 48.0 | 1.1 | 1.0 | 95 K | 27 K | 0 |
| Gross Profit | (46.5) | 0.3 | (0.7) | 95 K | 27 K | 1.2 |
| OPERATING INCOME | ||||||
| Operating Expenses | 20.6 | 56.4 | 43.9 | 22.2 | 16.5 | 8.5 |
| Selling, General and Administrative Expenses | 19.1 | 17.6 | 14.2 | 9.7 | 4.5 | 3.5 |
| Research and Development Expenses | 48.0 | 38.8 | 29.7 | 12.5 | 12.0 | 5.0 |
| Operating Income | (67.1) | (56.3) | (43.6) | (22.2) | (16.5) | (7.3) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 0 | 0.5 | 0 | 0 | 0 | 0 |
| Total Other Income | 4.5 | 1.0 | 0.1 | 82 K | 0.2 | 1.2 |
| Pre-Tax Income | (62.6) | (55.3) | (43.5) | (22.1) | (16.3) | (6.0) |
| NET INCOME | ||||||
| Tax Provision | 59 K | 13 K | (1.1) | 82 K | (0.2) | (1.2) |
| Net Income | (62.7) | (55.3) | (42.4) | (22.0) | (16.1) | (6.0) |
| EPS | 1.26 | 1.83 | 3.27 | 2.57 | 1.25 | 0.96 |